Phase 1 Hematologic Diseases Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Hematologic Diseases
Porteus, Matthew, MD22 enrolled1 locationNCT04640987
Recruiting
Phase 1
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
NeoplasmsHematologic Diseases
Zhejiang University20 enrolled1 locationNCT07257640
Recruiting
Phase 1Phase 2
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
NeoplasmsHematologic Diseases
Zhejiang University30 enrolled1 locationNCT05827835
Recruiting
Phase 1
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic Diseases
He Huang29 enrolled1 locationNCT06809699
Recruiting
Phase 1
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
NeoplasmsMultiple MyelomaCardiovascular Diseases+11 more
OriCell Therapeutics Co., Ltd.81 enrolled1 locationNCT06271252